Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… settings. In addition to providing the basis for multiple publications and presentations, these findings contribute …
… analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate … and transparent model Developing documents and publications to communicate the value of your product …
… real-world evidence (RWE) at every stage of your drug or device development journey. Experienced Real-World …
… debilitating and terminal illnesses with no effective therapies, the standard statistical threshold for determining … resources can be allocated more efficiently, bringing more therapies to more patients faster and more cost-effectively. … Articles: New Clinical Trial Approach For Urgently Needed Therapies Could Be On Horizon , Oct 25, 2016, by Reed Miller …
… FDA approval can help improve patient access to emerging therapies and devices. Work with our team to create your PIE …
… PLS to achieve meaningful patient involvement in drug or device development, registration, and reimbursement. …
… and reimbursement issues pertaining to clinical outcome assessments (COAs), we work with you to develop and …
… products before gaining regulatory approval by the US Food and Drug Administration to benefit eventual market … t is essential to determine key stakeholders and internal review committee members before beginning work on a UPD or … the inclusion of clinical data affect planned or pending publications? Manufacturers should determine the appropriate …
… literature reviews, and the preparation of institutional review board (IRB) protocols. Ms. Kosa has presented at … of the Academy of Nutrition and Dietetics, Journal of Food Protection , and other peer-reviewed journals. Prior to … the US Department of Agriculture (USDA), US Food and Drug Administration (FDA), Centers for Disease Control and …
… Communicable disease models Disease surveillance studies Drug utilization studies Economic burden of illness studies …